These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9645190)

  • 21. Characterization of peripheral blood progenitor cells mobilized by nartograstim (N-terminal replaced granulocyte colony-stimulating factor) in normal volunteers.
    Maruyama K; Tsuji K; Tanaka R; Yamada K; Kodera Y; Nakahata T
    Bone Marrow Transplant; 1998 Aug; 22(4):313-20. PubMed ID: 9722064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of angiotensin II on hematopoietic progenitor cell proliferation.
    Rodgers KE; Xiong S; Steer R; diZerega GS
    Stem Cells; 2000; 18(4):287-94. PubMed ID: 10924095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV.
    Nathwani AC; Hanawa H; Vandergriff J; Kelly P; Vanin EF; Nienhuis AW
    Gene Ther; 2000 Feb; 7(3):183-95. PubMed ID: 10694794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes.
    Deaglio S; Mallone R; Baj G; Arnulfo A; Surico N; Dianzani U; Mehta K; Malavasi F
    Chem Immunol; 2000; 75():99-120. PubMed ID: 10851781
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytokine expansion culture of cord blood CD34+ cells induces marked and sustained changes in adhesion receptor and CXCR4 expressions.
    Denning-Kendall P; Singha S; Bradley B; Hows J
    Stem Cells; 2003; 21(1):61-70. PubMed ID: 12529552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells.
    Wu MH; Smith SL; Dolan ME
    Stem Cells; 2001; 19(6):492-9. PubMed ID: 11713340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expansion of HPCs from cord blood in a novel 3D matrix.
    Ehring B; Biber K; Upton TM; Plosky D; Pykett M; Rosenzweig M
    Cytotherapy; 2003; 5(6):490-9. PubMed ID: 14660045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The murine stromal cell line AFT024 acts specifically on human CD34+CD38- progenitors to maintain primitive function and immunophenotype in vitro.
    Thiemann FT; Moore KA; Smogorzewska EM; Lemischka IR; Crooks GM
    Exp Hematol; 1998 Jul; 26(7):612-9. PubMed ID: 9657136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymic and signal transduction properties of CD38/NADase and PC-1/phosphodiesterase.
    Katada T; Kontani K; Wada T; Hosoda N; Hoshino S; Nishina H
    Chem Immunol; 2000; 75():60-78. PubMed ID: 10851779
    [No Abstract]   [Full Text] [Related]  

  • 31. CD38 in hematopoiesis.
    Campana D; Suzuki T; Todisco E; Kitanaka A
    Chem Immunol; 2000; 75():169-88. PubMed ID: 10851784
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood.
    Schipper LF; Brand A; Reniers NC; Melief CJ; Willemze R; Fibbe WE
    Br J Haematol; 1998 Jun; 101(3):425-35. PubMed ID: 9633882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD38 in hematopoietic malignancies.
    Konopleva M; Rissling I; Andreeff M
    Chem Immunol; 2000; 75():189-206. PubMed ID: 10851785
    [No Abstract]   [Full Text] [Related]  

  • 34. [Regulatory role of CD38 in humoral immune responses].
    Yokoyama M
    Seikagaku; 1999 Jun; 71(6):438-42. PubMed ID: 10432837
    [No Abstract]   [Full Text] [Related]  

  • 35. Cellular and molecular aspects of human CD34+ CD38- precursors: analysis of a primitive hematopoietic population.
    Xiao M; Dooley DC
    Leuk Lymphoma; 2000 Aug; 38(5-6):489-97. PubMed ID: 10953969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing phenotypes of hematopoietic stem cells.
    Ogawa M
    Exp Hematol; 2002 Jan; 30(1):3-6. PubMed ID: 11823030
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells.
    Dybedal I; Bryder D; Fossum A; Rusten LS; Jacobsen SE
    Blood; 2001 Sep; 98(6):1782-91. PubMed ID: 11535512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative assessment of gene expression in highly purified hematopoietic cells using real-time reverse transcriptase polymerase chain reaction.
    Raaijmakers MH; van Emst L; de Witte T; Mensink E; Raymakers RA
    Exp Hematol; 2002 May; 30(5):481-7. PubMed ID: 12031655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD38: an 'orphan' protein that may be finding a home?
    Felgar RE
    Leuk Res; 2000 Feb; 24(2):161-2. PubMed ID: 10654452
    [No Abstract]   [Full Text] [Related]  

  • 40. P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells.
    Lee BC; Cheng T; Adams GB; Attar EC; Miura N; Lee SB; Saito Y; Olszak I; Dombkowski D; Olson DP; Hancock J; Choi PS; Haber DA; Luster AD; Scadden DT
    Genes Dev; 2003 Jul; 17(13):1592-604. PubMed ID: 12842911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.